128 MRSA, 50 Years On: Where Do We Go from Here?

Sunday, March 21, 2010: 4:00 PM-6:00 PM
Regency VI-VII (Hyatt Regency Atlanta)
CME Credits: 2
Type: Oral
Summary: We are now 50 years into the global MRSA epidemic. What have we learned, and how can that knowledge be translated into effective prevention strategies? This session will begin with a broad overview of the global epidemiology of this successful pathogen, describing its emergence, evolution, and spread worldwide. The next speaker will summarize the wide variety of prevention approaches taken on the continent of Europe, and assess the effectiveness of these strategies and what they say about future prevention efforts. The next presentation will look ahead to the potential role of vaccination and immunotherapy for prevention and/or treatment of S. aureus infections. Finally, the session will examine the role of the media in public perception of the MRSA threat.
Learning Objectives:
Co-Organized by:
Association for Medical Microbiology and Infectious Disease Canada (AMMI-Canada) and the Canadian Association for Clinical Microbiology and Infectious Diseases (CACMID)
Mark E. Rupp, MD and Andreas Voss, MD
4:00 PM
MRSA Turns 50: Five Decades of Global Evolution and Spread
Henry Chambers, MD, University of California, San Francisco
4:30 PM
MRSA Prevention: Is Europe Winning the Fight Against MRSA?
Marc Struelens, MD, Hospital Erasme-Microbiology
5:00 PM
New Horizons for MRSA Prevention and Treatment: Vaccination and Immunotherapy
Stanley Deresinski, MD, California Infectious Diseases Associates
5:30 PM
MRSA and the Media
Eli Perencevich, MD, University of Iowa, Carver College of Medicine and the Iowa City VA Medical Center